CNN’s Alisyn Camerota: fact-checking claimed “costs” of Down syndrome lives

In discussing a recent state bill to ban Down syndrome selective abortions, CNN's Alisyn Camerota corrected her guest on his figures, but the ones she cited are even more troubling.  Continue Reading

The NDSC & DSMIG Conferences: Alzheimer’s, regression, resources, & friends

How can a person have Alzheimer's, but not? I learned about this and more at the 2015 National Down Syndrome Congress' annual convention in Phoenix, Arizona. Continue Reading

A sick, unethical cycle: prenatal testing for Down syndrome

So many items have cropped up in the past two weeks that here is a listing of all this news about Down syndrome prenatal testing. They lead to a sad conclusion. Continue Reading

Photo tour of ACMG 2015

Last week, I attended and presented at the American College of Medical Genetics & Genomics annual meeting in Salt Lake City, Utah. Here is a photo tour from the conference.  Continue Reading

Published! & Presenting at #ACMGMtg

The current edition of the American Journal of Bioethics Empirical Bioethics is devoted to non-invasive prenatal screening. I was fortunate to have an article published in the issue and will present part of that research at this week's American College of Medical Genetics & Genomics Annual Meeting.  Continue Reading

What’s (still) missing from the new prenatal test

At the beginning of February, the Society for Maternal-Fetal Medicine held its annual conference. Again it was reported that the new non-invasive prenatal test is inferior to traditional screening because it misses too many conditions. Continue Reading

From the news page: NHL, NPR, NIH, & Baby Gammy Update

From the News page, some good news, some incorrect news (reporting), and a new development for Baby Gammy: Continue Reading

Sting operation raises concerns about Sequenom’s, verifi’s accuracy

In the Fall of 2014, two maternal-fetal medicine specialists ran a sting operation on the non-invasive prenatal screening (NIPS) labs. Their operation reported embarrassing results for Sequenom and Illumina. Continue Reading

One-half of the problem with the new prenatal tests for Down syndrome

An investigative report calls attention to one-half of the problem with the new non-invasive prenatal screening tests for Down syndrome and other conditions.  Continue Reading